#MASH #Hepatology #GLP1 #PharmaInsights To view or add a comment, sign in Im excited to share the recent FDA approval of Jascayd (nerandomilast), the first new oral treatment for idiopathic pulmonary fibrosis (IPF) in over a decade
Subsequent, more restrictive recommendations limit carnitine supplements to those children with overdoses above 400 mg/kg
An allergy to sulfonamides does not imply a definite cross-reactivity with sulfites or elemental sulfur, as in methionine
CagriSema a combination of semaglutide and cagrilintide (an amylin analogue) had Phase 3 topline data in March 2025, and Amycretin, a single-molecule GLP-1/amylin dual, is entering Phase 3 in 2026
Benefits: Supports energy production by facilitating the transport of fatty acids into the mitochondria
A healthcare provider knowledgeable in peptide therapies and metabolic health must be involved